U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962280) titled 'A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight' on May 06.
Brief Summary: The main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 20 months.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Type 1 Diabetes
Obesity
Overweight
Intervention:
DRUG: Tirzepatide
Administered SC
DRUG: Placebo
Administered SC
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Eli Lilly and Company
Published by HT Digital Content Servic...